Last year, Nexalin Technology Inc generated 136.00K USD for its biggest-performing segment, Device Sales. The International Sales made the largest contribution, accounting for 190.30K USD last year. For the latest quarter, Nexalin Technology Inc reported the revenue of 52.53K USD for the period ending 2025-06-30, which came from the top-performing segment, Equipment . U.S. Sales contributed the highest revenue, at 12.16K USD.

By Business

Revenue

Proportion

Annual

Annual

Quarterly

Device Sales

Equipment

Licensing Fee

Other

Equipment

Royalty Fee

Treatment Fee

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

Device Sales

136.00K(45.09%)

55.50K(32.89%)

--(--)

1.16M(88.13%)

--(--)

Equipment

89.04K(29.52%)

--(--)

Licensing Fee

49.11K(16.28%)

69.50K(41.19%)

82.08K(74.11%)

79.19K(5.99%)

102.91K(71.43%)

116.18K(47.83%)

181.34K(87.44%)

Other

27.49K(9.11%)

5.89K(3.49%)

1.37K(1.24%)

26.41K(2.00%)

1.63K(1.13%)

966.00(0.40%)

1.90K(0.91%)

Equipment

--(--)

37.83K(22.42%)

27.30K(24.65%)

26.78K(2.03%)

39.53K(27.44%)

125.77K(51.78%)

18.28K(8.81%)

Royalty Fee

--(--)

24.48K(1.85%)

--(--)

Treatment Fee

--(--)

5.88K(2.83%)

By Region

Revenue

Proportion

Annual

Annual

Quarterly

International Sales

U.S. Sales

China Sales

FY2025

FY2024

FY2023

FY2022

International Sales

190.30K(63.09%)

--(--)

U.S. Sales

111.35K(36.91%)

83.47K(49.47%)

107.13K(96.74%)

113.54K(8.59%)

China Sales

--(--)

85.25K(50.53%)

3.61K(3.26%)

1.21M(91.41%)